A Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid Leukemia

NCT07743112 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: MAX-40279
DRUG: Azacitidine
DRUG: Venetoclax

Sponsor

Maxinovel Pty., Ltd.